Suppr超能文献

非去极化、正常血钾浓度的心脏停搏液配方腺苷-利多卡因(阿多卡因)通过其成分的协同作用发挥抗中性粒细胞作用。

The nondepolarizing, normokalemic cardioplegia formulation adenosine-lidocaine (adenocaine) exerts anti-neutrophil effects by synergistic actions of its components.

机构信息

Cardiothoracic Research Laboratory, Carlyle Fraser Heart Center, Emory University, 550 Peachtree Street NE, Atlanta, GA 30308-2225, USA.

出版信息

J Thorac Cardiovasc Surg. 2012 May;143(5):1167-75. doi: 10.1016/j.jtcvs.2011.06.045. Epub 2011 Nov 12.

Abstract

OBJECTIVE

A new strategy of normothermic cardioplegia based on the combination of adenosine and lidocaine (adenocaine; Hibernation Therapeutics Global Ltd, Kilquade, Ireland) achieves nondepolarized arrest at normokalemia. Both adenosine and lidocaine independently inhibit neutrophil (polymorphonuclear neutrophil; PMN) activity. However, whether adenocaine exerts greater anti-inflammatory effects is not known. We tested the hypothesis that adenocaine synergistically attenuates PMN functions.

METHODS

Superoxide anion (O(2)(-)) generation: Isolated porcine PMNs were primed with cytochalasin B (5 μg/mL) and activated by N-formylmethionyl-leucyl-phenylalanine (100 nM). O(2)(-) release was quantified using lucigenin-enhanced chemiluminescence. Data were expressed as percent of stimulated control.

RESULTS

Both adenosine and lidocaine alone inhibited O(2)(-) production in a dose-dependent manner (adenosine reduced to 67% ± 8.4% and 21% ± 2.2% of maximal stimulation at 0.1 and 10 μmol/L, respectively, lidocaine reduced to 57.9% ± 18.6% and 28% ± 5% at 10 and 100 μmol/L, respectively). Adenocaine further reduced O(2)(-) generation in a synergistic manner. In addition, adenosine alone (0.1-10 μmol/L) inhibited O(2)(-) generation in primed but not activated PMNs, whereas lidocaine alone (1-100 μmol/L) inhibited O(2)(-) release in both primed and activated PMNs. Adenocaine further reduced O(2)(-) generation because of inhibition of both priming and activation stages. Both adenosine and lidocaine alone and adenocaine comparably inhibited platelet activating factor-induced CD11 b/c surface expression on PMNs (flow cytometry), but adenocaine further suppressed both CD18 expression (to 47.4% ± 9.7%) and PMN adherence (to 47.2% ± 4.3%) compared with adenosine and lidocaine alone. Transmigration of calcein-acetyoxymethyl-labeled PMNs through transwells seeded with cultured coronary artery endothelial cells was reduced comparably by adenosine (to 80.1% ± 6.7%) and adenocaine (67.3% ± 9.6%).

CONCLUSIONS

Adenocaine suppresses multiple PMN functions including O(2)(-) generation, adhesion molecule expression, PMN adherence, and transmigration. In addition to inducing nondepolarized arrest, adenocaine cardioplegia may exert cardioprotection by inhibiting PMN-mediated inflammatory responses.

摘要

目的

基于腺苷和利多卡因(爱尔兰基尔奎德的 Hibernation Therapeutics Global Ltd. 生产的腺嘌呤)组合的常温心脏停搏新策略可实现正常血钾浓度下的非去极化停搏。腺苷和利多卡因均可独立抑制中性粒细胞(多形核中性粒细胞;PMN)的活性。然而,腺嘌呤是否具有更大的抗炎作用尚不清楚。我们检验了腺嘌呤是否协同抑制 PMN 功能的假说。

方法

超氧阴离子(O(2)(-))生成:分离的猪 PMN 用细胞松弛素 B(5 μg/mL)预刺激,并通过 N-甲酰甲硫氨酰-亮氨酰-苯丙氨酸(100 nM)激活。使用荧光素增强化学发光法定量 O(2)(-)释放。数据表示为刺激对照的百分比。

结果

腺苷和利多卡因单独使用时均呈剂量依赖性抑制 O(2)(-)生成(0.1 和 10 μmol/L 时,腺嘌呤分别降至最大刺激的 67%±8.4%和 21%±2.2%;10 和 100 μmol/L 时,利多卡因分别降至 57.9%±18.6%和 28%±5%)。腺嘌呤以协同方式进一步降低 O(2)(-)生成。此外,腺苷单独(0.1-10 μmol/L)抑制预刺激但不激活的 PMN 中的 O(2)(-)生成,而利多卡因单独(1-100 μmol/L)抑制预刺激和激活的 PMN 中的 O(2)(-)释放。腺嘌呤进一步降低 O(2)(-)生成,因为它抑制了刺激和激活两个阶段。腺苷和利多卡因单独使用以及腺嘌呤均可抑制血小板激活因子诱导的 PMN 表面 CD11b/c 表达(流式细胞术),但与腺苷和利多卡因单独使用相比,腺嘌呤进一步抑制 CD18 表达(至 47.4%±9.7%)和 PMN 黏附(至 47.2%±4.3%)。用 calcein-乙酰氧甲基标记的 PMN 通过穿过培养的冠状动脉内皮细胞接种的 Transwell 进行的迁移也被腺苷(至 80.1%±6.7%)和腺嘌呤(至 67.3%±9.6%)相当程度地抑制。

结论

腺嘌呤抑制包括 O(2)(-)生成、黏附分子表达、PMN 黏附以及迁移在内的多种 PMN 功能。除了诱导非去极化停搏外,腺嘌呤心脏停搏液还可能通过抑制 PMN 介导的炎症反应来发挥心脏保护作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验